OTLK icon

Outlook Therapeutics

Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$2.5
771% upside
High target

3 analyst ratings

positive
neutral
67%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Ascendiant Capital
Ascendiant Capital
Edward Woo
25% 1-yr OTLK win rate
11 Mar ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
18 Feb ‘26 2 months ago
Chardan Capital
Chardan Capital
Daniil Gataulin
18 Feb ‘26 2 months ago